[
    [
        {
            "time": "",
            "original_text": "首个国产新冠mRNA疫苗车间建成 沃森生物再获8463万元对抗“变异新株”",
            "features": {
                "keywords": [
                    "国产",
                    "新冠",
                    "mRNA疫苗",
                    "车间建成",
                    "沃森生物",
                    "8463万元",
                    "变异新株"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "首个国产新冠mRNA疫苗车间建成 沃森生物再获8463万元对抗“变异新株”",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]